The Ricoh Group collaborates with our valued customers to pioneer new innovations in the realm of mRNA drug discovery by leveraging our core technology in mRNA design, production, and management.
The Ricoh Group operates a manufacturing facility located in Shonan Health Innovation Park, Japan, where we offer extensive mRNA contract manufacturing services covering the entire spectrum from research to clinical applications. We welcome specific requests, including those for small quantities and various types, and encourage you to consult with us. Our services include meticulous quality control procedures, including various QC tests and analytical services, all conducted within a stringent quality control system compliant with cGMP standards.
We offer specialized guidance and assistance to researchers in optimizing mRNA vaccine and mRNA drug sequences. Our dedicated team, composed of mRNA manufacturing experts and molecular biology specialists, delivers tailored solutions designed to meet your specific requirements. This service plays a crucial role in advancing the development of safe and effective mRNA drugs.